Answers are grounded in this paper and cite their sources.
Introduction: Metastatic colorectal cancers (mCRC) are highly heterogeneous, representing a challenge in treatment management. Studies have largely investigated the genomic landscape of primary tumors at diagnosis. As metastasis is responsible for 90% of cancer patient deaths, this highlights the need to characterize the genomic landscape of metastasis over time of treatment to decipher their evolution and role in therapeutic resistance.
No takes yet. Share an insight, caveat, or question.
Marques et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: